PCM Encore, LLC

SEC CIK: 0002109846
Latest filing: Aug 11, 2026

SEC filings (opens in a new tab)

NVO holding history

Novo Nordisk A S in every 13F filed by PCM Encore, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVO overview All 13F holders of NVO Full Q2 2026 holdings

Shares (Q2 2026): 17,502
Value: $839.0K
% of portfolio: 0.1%
Quarters held: 3; Since Q4 2025

Holdings of NVO by PCM Encore, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	17,502	$839.0K	0.1%	−5,007−22.2%	Reduced	Holders
Q1 2026	22,509	$827.2K	0.2%	+801+3.7%	Added	Holders
Q4 2025	21,708	$1.10M	0.2%	–	No prior filing	Holders